Jaguar Health Inc reports results for the quarter ended in March - Earnings Summary

• Jaguar Health Inc JAGX reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended in March. The lone analyst forecast for the quarter was for a loss of 3 cents per share.

• Revenue was $2.35 million​; analysts expected $2.96 million.

• Jaguar Health Inc's reported EPS for the quarter was a loss of 6 cents​.

• The company reported a quarterly loss of $9.23 million.

• Jaguar Health Inc shares had risen by 222.9% this quarter and gained 91.7% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• Wall Street's median 12-month price target for Jaguar Health Inc is $0.60

This summary was machine generated from LSEG data May 14 at 03:49 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)